Pandemic Treaty Could Have IP & Other Implications For Pharma
Early Days But WHO Is Hoping For Wide-Ranging Change
Executive Summary
Equitable access to pandemic medicines and vaccines will be at the core of the WHO’s future global pandemic treaty. Exactly what this will mean for the pharmaceutical industry remains to be seen, but it is likely that companies wanting access to virus samples and other materials will need to agree to benefit sharing in the form of IP and technology transfer.